The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Tpp2  -  tripeptidyl peptidase II

Mus musculus

Synonyms: TPP-2, TPP-II, TppII, Tripeptidyl aminopeptidase, Tripeptidyl-peptidase 2, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Tpp2

  • We demonstrate here that tripeptidyl peptidase II (TPPII), a cytoplasmic, high-molecular-weight protease, participates in the apoptotic pathway triggered by Shigella [1].
  • These results suggest that the activities of both the proteasome and TPPII are regulated in a parallel manner in cancer cachexia, and that both are induced by the same factor and probably have the same intracellular signalling pathways and transcription factors [2].
  • To investigate if a relationship exists between the activity of the proteasome and TPPII, functional activities have been measured in gastrocnemius muscle of mice bearing the MAC16 tumour, and with varying extents of weight loss [2].
 

High impact information on Tpp2

  • We also find, in studies of apoptosis resistant cells derived from large in vivo tumors, that these have acquired an altered peptidase activity, with up-regulation of TPP II activity and decreased proteasomal activity [3].
  • However, proteasomes in vivo (like purified proteasomes) release relatively few such peptides, and these peptides processed by TPPII require further trimming in the endoplasmic reticulum (ER) by ER aminopeptidase 1 for presentation [4].
  • Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation [4].
  • However, our results suggest that eubacterial PepN and its homologues displaying aminoendopeptidase activities may be "functionally similar" to enzymes important in downstream processing of proteins in the cytosol: Tricorn-F1-F2-F3 complex in Archaea and TPPII/Multicorn in eukaryotes [5].
  • Both AAF-cmk and lactacystin prevented the maturation of pro-caspase-1 and its substrate pro-interleukin 1beta in Shigella-infected macrophages, indicating that TPPII is upstream of caspase-1 [1].
 

Biological context of Tpp2

 

Anatomical context of Tpp2

  • This was surprising because native human TPP II is purified from erythrocytes as an active oligomeric complex, and the amino-acid sequences of the human and murine enzymes were 96% identical [8].
  • Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle [2].
  • In murine myotubes, proteolysis-inducing factor, which is a sulphated glycoprotein produced by cachexia-inducing tumours, induced an increase in activity of both proteasome and TPPII, with an identical dose-response curve, and both activities were inhibited by eicosapentaenoic acid [2].
 

Associations of Tpp2 with chemical compounds

  • The TPPII inhibitor Ala-Ala-Phe-chloromethylketone (AAF-cmk) and clasto-lactacystin beta-lactone (lactacystin), an inhibitor of both TPPII and the proteasome, protected macrophages from Shigella-induced apoptosis [1].
  • Administration of the lowest sublethal dosage of TOCP (0.25g/1Kg, 24 hours) resulted in significant inhibition (10 to 30% of control activity) of the cytoplasmic proteases tripeptidyl aminopeptidase and proline endopeptidase only [9].
 

Other interactions of Tpp2

  • Consequently, higher concentrations of butabindide are required for the inhibition of CCK-8S degradation by TPP-I than by TPP-II [10].
  • An increasing dosage of TOCP (1g/Kg for 7 days) resulted in significant inhibition (10 to 50% of control activity) of the cytoplasmic proteases alanyl aminopeptidase, leucyl aminopeptidase, tripeptidyl aminopeptidase, and proline endopeptidase, as well as the lysosomal proteases dipeptidyl aminopeptidase I and cathepsins B, D, and L [9].

References

  1. Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis. Hilbi, H., Puro, R.J., Zychlinsky, A. Infect. Immun. (2000) [Pubmed]
  2. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle. Chand, A., Wyke, S.M., Tisdale, M.J. Cancer Lett. (2005) [Pubmed]
  3. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. Hong, X., Lei, L., Glas, R. J. Exp. Med. (2003) [Pubmed]
  4. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. York, I.A., Bhutani, N., Zendzian, S., Goldberg, A.L., Rock, K.L. J. Immunol. (2006) [Pubmed]
  5. PepN, the major Suc-LLVY-AMC-hydrolyzing enzyme in Escherichia coli, displays functional similarity with downstream processing enzymes in Archaea and eukarya. Implications in cytosolic protein degradation. Chandu, D., Kumar, A., Nandi, D. J. Biol. Chem. (2003) [Pubmed]
  6. Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing. Tomkinson, B. Biochem. J. (1994) [Pubmed]
  7. The gene encoding tripeptidyl peptidase II maps to chromosome 1 in the mouse. Bermingham, N.A., McKay, T., Hoyle, J., Hernandez, D., Martin, J.E., Fisher, E.M. Mamm. Genome (1996) [Pubmed]
  8. The insert within the catalytic domain of tripeptidyl-peptidase II is important for the formation of the active complex. Tomkinson, B., Ní Laoi, B., Wellington, K. Eur. J. Biochem. (2002) [Pubmed]
  9. Effect of Tri-O-cresyl phosphate (TOCP) on proteolytic enzyme activities in mouse liver in vivo. Saleem, M.A., Williams, F.M., Wilkins, R.M., Shakoori, A.R., Mantle, D. J. Environ. Pathol. Toxicol. Oncol. (1998) [Pubmed]
  10. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes. Warburton, M.J., Bernardini, F. Neurosci. Lett. (2002) [Pubmed]
 
WikiGenes - Universities